Moertel Cg

1.4k total citations
53 papers, 1.1k citations indexed

About

Moertel Cg is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Moertel Cg has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in Moertel Cg's work include Gastric Cancer Management and Outcomes (13 papers), Colorectal Cancer Treatments and Studies (13 papers) and Cancer therapeutics and mechanisms (7 papers). Moertel Cg is often cited by papers focused on Gastric Cancer Management and Outcomes (13 papers), Colorectal Cancer Treatments and Studies (13 papers) and Cancer therapeutics and mechanisms (7 papers). Moertel Cg collaborates with scholars based in United States. Moertel Cg's co-authors include Robert G. Hahn, Schutt Aj, Susan Galandiuk, Pemberton Jh, Wieand Hs, Fitzgibbons Rj, Sun‐Shin Cha, PT Lavin, O'Connell Mj and Joseph Rubin and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Moertel Cg

51 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Moertel Cg United States	19	717	326	300	171	159	53	1.1k
Hugh L. Davis United States	19	517 0.7×	276 0.8×	221 0.7×	180 1.1×	87 0.5×	46	1.1k
Joseph D. McCracken United States	19	766 1.1×	416 1.3×	288 1.0×	212 1.2×	283 1.8×	35	1.4k
A.S.T. Planting Netherlands	19	681 0.9×	236 0.7×	182 0.6×	254 1.5×	170 1.1×	31	1.2k
S. J. Harland United Kingdom	18	390 0.5×	219 0.7×	410 1.4×	105 0.6×	134 0.8×	32	1.1k
James Raschko United States	20	416 0.6×	179 0.5×	223 0.7×	112 0.7×	57 0.4×	50	1.1k
Jacob Colsky United States	16	449 0.6×	176 0.5×	74 0.2×	92 0.5×	99 0.6×	40	899
Harry H. Miller United States	12	436 0.6×	139 0.4×	405 1.4×	52 0.3×	288 1.8×	26	951
M Soukop United Kingdom	19	575 0.8×	169 0.5×	215 0.7×	234 1.4×	69 0.4×	48	1.1k
Richárd Schwab Hungary	18	260 0.4×	323 1.0×	296 1.0×	55 0.3×	89 0.6×	51	791
Martin Wiesenfeld United States	19	626 0.9×	210 0.6×	75 0.3×	137 0.8×	142 0.9×	33	982

Countries citing papers authored by Moertel Cg

Since Specialization

Citations

This map shows the geographic impact of Moertel Cg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moertel Cg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moertel Cg more than expected).

Fields of papers citing papers by Moertel Cg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moertel Cg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moertel Cg. The network helps show where Moertel Cg may publish in the future.

Co-authorship network of co-authors of Moertel Cg

This figure shows the co-authorship network connecting the top 25 collaborators of Moertel Cg. A scholar is included among the top collaborators of Moertel Cg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moertel Cg. Moertel Cg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Purvis, J., et al.. (1981). Phase II study of PALA in advanced large bowel carcinoma.. PubMed. 65(3-4). 335–6. 9 indexed citations

Cg, Moertel & PT Lavin. (1980). Phase II-III chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology Group.. PubMed. 63(11-12). 1863–9. 42 indexed citations

Mj, O'Connell, et al.. (1980). Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinoma.. PubMed. 64(2-3). 311–3. 4 indexed citations

Mj, O'Connell, Adi Shani, Joshua T. Rubin, & Moertel Cg. (1978). Phase II trial of maytansine in patients with advanced colorectal carcinoma.. PubMed. 62(8). 1237–8. 10 indexed citations

Gm, Tyce, et al.. (1977). The carcinoid syndrome--a role for hemodialysis.. PubMed. 61(1). 107–8. 1 indexed citations

Cg, Moertel, et al.. (1976). Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 60(9). 1247–50. 20 indexed citations

Cg, Moertel. (1976). Walter Hubert lecture Chemotherapy of upper gastrointestinal carcinoma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 34(3). 325–34. 4 indexed citations

Ho, Douglass, PT Lavin, & Moertel Cg. (1976). Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.. PubMed. 60(6). 769–80. 18 indexed citations

Cg, Moertel, et al.. (1975). Phase II study of chromomycin A3 (NSC-58514) in advanced colorectal carcinoma.. PubMed. 59(3). 577–9. 2 indexed citations

10.

Cg, Moertel, et al.. (1974). Treatment of advanced squamous cell carcinoma of the gastrointestinal tract with bleomycin (NSC-125066).. PubMed. 57(4). 493–5. 19 indexed citations

11.

Cg, Moertel, et al.. (1974). Phase I study of chromomycin A (NSC-58514).. PubMed. 57(3). 341–7. 2 indexed citations

12.

Cg, Moertel, et al.. (1974). Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel.. PubMed. 57(3). 357–9. 42 indexed citations

13.

Cg, Moertel, et al.. (1972). Effect of concomitant drug treatment on toxic and therapeutic activity of 5-fluorouracil (5-FU; NSC-19893).. PubMed. 56(2). 245–7. 1 indexed citations

14.

Cg, Moertel, et al.. (1972). Effect of resection of the primary neoplasm on responsiveness to chemotherapy of patients with large bowel cancer.. PubMed. 56(4). 551–2. 2 indexed citations

15.

Cg, Moertel, et al.. (1972). Phase II study of bleomycin (NSC-125066) therapy for large bowel cancer.. PubMed. 56(2). 207–10. 3 indexed citations

16.

Cg, Moertel, et al.. (1970). 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.. PubMed. 54(6). 471–3. 3 indexed citations

17.

Cg, Moertel, et al.. (1969). Comparative response of carcinoma of the rectum and carcinoma of the colon to fluorinated pyrimidine therapy.. PubMed. 53(5). 283–5. 4 indexed citations

18.

Cg, Moertel, et al.. (1964). VINCRISTINE (NSC-67574) THERAPY OF ADULT PATIENTS WITH SOLID TUMORS.. PubMed. 34. 21–3. 8 indexed citations

19.

Cg, Moertel, et al.. (1964). CEREBELLAR ATAXIA ASSOCIATED WITH FLUORINATED PYRIMIDINE THERAPY.. PubMed. 41. 15–8. 42 indexed citations

20.

Cg, Moertel, et al.. (1962). Comparison of rapid and slow intravenous administration of 5-fluorouracil in treating patients with advanced carcinoma of the large intestine.. PubMed. 25. 87–9. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact